Preclinical data on the novel NPY Y2 receptor antagonist JNJ-31020028 disclosed at Neuroscience 2009 Oct. 22, 2009
AN-2728 5% ointment applied twice daily for 6-8 weeks is beneficial in plaque psoriasis therapy Oct. 22, 2009